{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:33:35Z","timestamp":1789605215345,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research Development Fund of Beijing Municipal Health Commission","award":["2019-4"],"award-info":[{"award-number":["2019-4"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-026-04909-3","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:24:11Z","timestamp":1779377051000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety and pharmacokinetics of intravitreally repeatedly injected panitumumab in non-human primates - a study performed under good laboratory practice"],"prefix":"10.1186","volume":"26","author":[{"given":"Ya Xing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank G.","family":"Holz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Coenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wankun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songhomitra","family":"Panda-Jonas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jost B.","family":"Jonas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"issue":"6","key":"4909_CR1","first-page":"1183","volume":"36","author":"Y Seko","year":"1995","unstructured":"Seko Y, Shimokawa H, Tokoro T. Expression of bFGF and TGF-beta 2 in experimental myopia in chicks. Invest Ophthalmol Vis Sci. 1995;36(6):1183\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"4909_CR2","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1016\/j.ophtha.2006.05.062","volume":"113","author":"WH Chua","year":"2006","unstructured":"Chua WH, Balakrishnan V, Chan YH, et al. Atropine for the treatment of childhood myopia. Ophthalmology. 2006;113(12):2285\u201391.","journal-title":"Ophthalmology"},{"issue":"10","key":"4909_CR3","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s00417-006-0254-1","volume":"244","author":"Q Gao","year":"2006","unstructured":"Gao Q, Liu Q, Ma P, Zhong X, Wu J, Ge J. Effects of direct intravitreal dopamine injections on the development of lid-suture induced myopia in rabbits. Graefes Arch Clin Exp Ophthalmol. 2006;244(10):1329\u201335.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4909_CR4","first-page":"1277","volume":"15","author":"VA Barathi","year":"2009","unstructured":"Barathi VA, Weon SR, Beuerman RW. Expression of muscarinic receptors in human and mouse sclera and their role in the regulation of scleral fibroblasts proliferation. Mol Vis. 2009;15:1277\u201393.","journal-title":"Mol Vis"},{"issue":"3","key":"4909_CR5","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.exer.2008.10.022","volume":"88","author":"AI Jobling","year":"2009","unstructured":"Jobling AI, Wan R, Gentle A, Bui BV, McBrien NA. Retinal and choroidal TGF-beta in the tree shrew model of myopia: isoform expression, activation and effects on function. Exp Eye Res. 2009;88(3):458\u201366.","journal-title":"Exp Eye Res"},{"key":"4909_CR6","first-page":"680","volume":"17","author":"VA Barathi","year":"2011","unstructured":"Barathi VA, Beuerman RW. Molecular mechanisms of muscarinic receptors in mouse scleral fibroblasts: Prior to and after induction of experimental myopia with atropine treatment. Mol Vis. 2011;17:680\u201392.","journal-title":"Mol Vis"},{"issue":"11","key":"4909_CR7","doi-asserted-by":"publisher","first-page":"7508","DOI":"10.1167\/iovs.14-14294","volume":"55","author":"L Jiang","year":"2014","unstructured":"Jiang L, Long K, Schaeffel F, et al. Effects of dopaminergic agents on progression of naturally occurring myopia in albino guinea pigs (Cavia porcellus). Invest Ophthalmol Vis Sci. 2014;55(11):7508\u201319.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"4909_CR8","first-page":"239","volume":"7","author":"XJ Li","year":"2014","unstructured":"Li XJ, Yang XP, Wan GM, Wang YY, Zhang JS. Effects of hepatocyte growth factor on MMP-2 expression in scleral fibroblasts from a guinea pig myopia model. Int J Ophthalmol. 2014;7(2):239\u201344.","journal-title":"Int J Ophthalmol"},{"issue":"2","key":"4909_CR9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","volume":"123","author":"A Chia","year":"2016","unstructured":"Chia A, Lu QS, Tan D. Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eye drops. Ophthalmology. 2016;123(2):391\u20139.","journal-title":"Ophthalmology"},{"issue":"11","key":"4909_CR10","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1177\/1535370216638773","volume":"241","author":"J Mao","year":"2016","unstructured":"Mao J, Liu S, Fu C. Citicoline retards myopia progression following form deprivation in guinea pigs. Exp Biol Med (Maywood). 2016;241(11):1258\u201363.","journal-title":"Exp Biol Med (Maywood)"},{"key":"4909_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ebiom.2017.02.021","volume":"17","author":"WJ Jiang","year":"2017","unstructured":"Jiang WJ, Song HX, Li SY, et al. Amphiregulin antibody and reduction of axial elongation in experimental myopia. EBioMedicine. 2017;17:134\u201344.","journal-title":"EBioMedicine"},{"issue":"3","key":"4909_CR12","doi-asserted-by":"publisher","first-page":"e460","DOI":"10.1111\/aos.14080","volume":"97","author":"L Dong","year":"2019","unstructured":"Dong L, Shi XH, Kang YK, et al. Amphiregulin and ocular axial length. Acta Ophthalmol. 2019;97(3):e460\u201370.","journal-title":"Acta Ophthalmol"},{"key":"4909_CR13","doi-asserted-by":"publisher","first-page":"e8436","DOI":"10.7717\/peerj.8436","volume":"8","author":"T Cheng","year":"2020","unstructured":"Cheng T, Wang J, Xiong S, et al. Association of IGF1 single-nucleotide polymorphisms with myopia in Chinese children. PeerJ. 2020;8:e8436.","journal-title":"PeerJ"},{"issue":"10","key":"4909_CR14","doi-asserted-by":"publisher","first-page":"13654","DOI":"10.1096\/fj.202001095RR","volume":"34","author":"L Dong","year":"2020","unstructured":"Dong L, Shi XH, Li YF, et al. Blockade of epidermal growth factor and its receptor and axial elongation in experimental myopia. FASEB J. 2020;34(10):13654\u201370.","journal-title":"FASEB J"},{"issue":"1","key":"4909_CR15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12886-022-02417-8","volume":"22","author":"L Dong","year":"2022","unstructured":"Dong L, Zhang RH, Zhou WD, et al. Epiregulin, epigen and betacellulin antibodies and axial elongation in young guinea pigs with lens-induced myopization. BMC Ophthalmol. 2022;22(1):193.","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"4909_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1167\/iovs.64.4.11","volume":"64","author":"L Dong","year":"2023","unstructured":"Dong L, Zhang RH, Wu HT, et al. Intravitreal short-hairpin RNA attenuated adeno-associated virus-induced knockdown of amphiregulin and axial elongation in experimental myopia. Invest Ophthalmol Vis Sci. 2023;64(4):11.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4909_CR17","doi-asserted-by":"publisher","first-page":"1277180","DOI":"10.3389\/fmed.2023.1277180","volume":"10","author":"XH Shi","year":"2023","unstructured":"Shi XH, Dong L, Zhang RH, et al. Reduction of experimental ocular axial elongation by neuregulin-1 antibody. Front Med (Lausanne). 2023;10:1277180.","journal-title":"Front Med (Lausanne)"},{"key":"4909_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fopht.2022.995157","author":"W Wang","year":"2022","unstructured":"Wang W, Nan Y, Huang T, Pu M, Jonas JB. Intraocular amphiregulin antibody and axial elongation in nonhuman primates. Front Ophthalmol. 2022. https:\/\/doi.org\/10.3389\/fopht.2022.995157.","journal-title":"Front Ophthalmol"},{"key":"4909_CR19","doi-asserted-by":"crossref","unstructured":"Dong L, Wu HT, Zhang RH, et al. Intraocular amphiregulin and axial elongation in non-human adolescent primates. Exp Eye Res. 2024; In print.","DOI":"10.1016\/j.exer.2024.110059"},{"issue":"8","key":"4909_CR20","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1097\/IAE.0000000000001464","volume":"37","author":"JB Jonas","year":"2017","unstructured":"Jonas JB, Ohno-Matsui K, Jiang WJ, Panda-Jonas S. Bruch membrane and the mechanism of myopization: A new theory. Retina. 2017;37(8):1428\u201340.","journal-title":"Retina"},{"key":"4909_CR21","doi-asserted-by":"publisher","first-page":"101156","DOI":"10.1016\/j.preteyeres.2022.101156","volume":"96","author":"JB Jonas","year":"2023","unstructured":"Jonas JB, Jonas RA, Bikbov MM, Wang YX, Panda-Jonas S, Myopia. Histology, clinical features, and potential implications for the etiology of axial elongation. Prog Retin Eye Res. 2023;96:101156.","journal-title":"Prog Retin Eye Res"},{"issue":"6","key":"4909_CR22","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.ophtha.2017.12.005","volume":"125","author":"Y Fang","year":"2018","unstructured":"Fang Y, Yokoi T, Nagaoka N, et al. Progression of myopic maculopathy during 18-year follow-up. Ophthalmology. 2018;125(6):863\u201377.","journal-title":"Ophthalmology"},{"issue":"5","key":"4909_CR23","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1136\/bjophthalmol-2019-314619","volume":"104","author":"MW Lee","year":"2020","unstructured":"Lee MW, Lee SE, Lim HB, Kim JY. Longitudinal changes in axial length in high myopia: a 4-year prospective study. Br J Ophthalmol. 2020;104(5):600\u20133.","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"4909_CR24","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1001\/jamaophthalmol.2021.3303","volume":"139","author":"R Du","year":"2021","unstructured":"Du R, Xie S, Igarashi-Yokoi T, et al. Continued increase of axial length and its risk factors in adults with high myopia. JAMA Ophthalmol. 2021;139(10):1096\u2013103.","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"4909_CR25","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1056\/NEJMoa1305275","volume":"369","author":"JY Douillard","year":"2013","unstructured":"Douillard JY, Oliner KS, Siena S, et al. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer. N Engl J Med. 2013;369(11):1023\u201334.","journal-title":"N Engl J Med"},{"issue":"6","key":"4909_CR26","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/bjo-2023-323383","volume":"108","author":"MM Bikbov","year":"2024","unstructured":"Bikbov MM, Kazakbaeva GM, Holz FG, et al. Intravitreal panitumumab and myopic macular degeneration. Br J Ophthalmol. 2024;108(6):859\u201364.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"4909_CR27","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1007\/s10792-021-01761-w","volume":"41","author":"MM Bikbov","year":"2021","unstructured":"Bikbov MM, Khalimov TA, Cerrada-Gimenez M, Ragauskas S, Kalesnykas G, Jonas JB. Compatibility of intravitreally applied epidermal growth factor and amphiregulin. Int Ophthalmol. 2021;41(6):2053\u201363.","journal-title":"Int Ophthalmol"},{"key":"4909_CR28","doi-asserted-by":"publisher","first-page":"109715","DOI":"10.1016\/j.exer.2023.109715","volume":"238","author":"HY Li","year":"2024","unstructured":"Li HY, Dong L, Shi XH, et al. Intraocular cetuximab: Safety and effect on axial elongation in young guinea pigs with lens-induced myopization. Exp Eye Res. 2024;238:109715.","journal-title":"Exp Eye Res"},{"issue":"2","key":"4909_CR29","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1001\/jamaophthalmol.2021.5067","volume":"140","author":"SS Lee","year":"2022","unstructured":"Lee SS, Lingham G, Sanfilippo PG, et al. Incidence and progression of myopia in early adulthood. JAMA Ophthalmol. 2022;140(2):162\u20139.","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"4909_CR30","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.ajo.2010.05.009","volume":"150","author":"N Saka","year":"2010","unstructured":"Saka N, Ohno-Matsui K, Shimada N, et al. Long-term changes in axial length in adult eyes with pathologic myopia. Am J Ophthalmol. 2010;150(4):562\u20138.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"4909_CR31","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00417-012-2066-9","volume":"251","author":"N Saka","year":"2013","unstructured":"Saka N, Moriyama M, Shimada N, et al. Changes of axial length measured by IOL master during 2 years in eyes of adults with pathologic myopia. Graefes Arch Clin Exp Ophthalmol. 2013;251(2):495\u20139.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"4909_CR32","doi-asserted-by":"publisher","first-page":"6621","DOI":"10.1038\/s41598-019-43212-8","volume":"9","author":"L Dong","year":"2019","unstructured":"Dong L, Shi XH, Kang YK, et al. Bruch\u2019s membrane thickness and retinal pigment epithelium cell density in experimental axial elongation. Sci Rep. 2019;9(1):6621.","journal-title":"Sci Rep"},{"issue":"7","key":"4909_CR33","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1167\/iovs.17-22069","volume":"59","author":"X Wang","year":"2018","unstructured":"Wang X, Teoh CKG, Chan ASY, Thangarajoo S, Jonas JB, Girard MJA. Biomechanical properties of Bruch\u2019s membrane-choroid complex and their influence on optic nerve head biomechanics. Invest Ophthalmol Vis Sci. 2018;59(7):2808\u201317.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"4909_CR34","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1167\/iovs.05-0445","volume":"46","author":"EL Smith","year":"2005","unstructured":"Smith EL 3rd, Kee CS, Ramamirtham R, Qiao-Grider Y, Hung LF. Peripheral vision can influence eye growth and refractive development in infant monkeys. Invest Ophthalmol Vis Sci. 2005;46(11):3965\u201372.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"4909_CR35","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1167\/iovs.06-0562","volume":"48","author":"DO Mutti","year":"2007","unstructured":"Mutti DO, Hayes JR, Mitchell GL. Refractive error, axial length, and relative peripheral refractive error before and after the onset of myopia. Invest Ophthalmol Vis Sci. 2007;48(6):2510\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"13","key":"4909_CR36","doi-asserted-by":"publisher","first-page":"9362","DOI":"10.1167\/iovs.11-7260","volume":"52","author":"P Sankaridurg","year":"2011","unstructured":"Sankaridurg P, Holden B, Smith E III. Decrease in rate of myopia progression with a contact lens designed to reduce relative peripheral hyperopia: one-year results. Invest Ophthalmol Vis Sci. 2011;52(13):9362\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"4909_CR37","doi-asserted-by":"publisher","first-page":"5761","DOI":"10.1167\/iovs.13-11904","volume":"54","author":"DA Berntsen","year":"2013","unstructured":"Berntsen DA, Barr CD, Mutti DO, Zadnik K. Peripheral defocus and myopia progression in myopic children randomly assigned to wear single vision and progressive addition lenses. Invest Ophthalmol Vis Sci. 2013;54(8):5761\u201370.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"4909_CR38","doi-asserted-by":"publisher","first-page":"M106","DOI":"10.1167\/iovs.18-25958","volume":"60","author":"CF Wildsoet","year":"2019","unstructured":"Wildsoet CF, Chia A, Cho P, et al. IMI - Interventions Myopia Institute: Interventions for controlling myopia onset and progression report. Invest Ophthalmol Vis Sci. 2019;60(3):M106\u201331.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"4909_CR39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1167\/iovs.64.10.24","volume":"64","author":"R Zhang","year":"2023","unstructured":"Zhang R, Dong L, Wu H, et al. mTORC1 signaling and negative lens-induced axial elongation. Invest Ophthalmol Vis Sci. 2023;64(10):24.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-026-04909-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04909-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-04909-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:18:17Z","timestamp":1784074697000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-026-04909-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4909"],"URL":"https:\/\/doi.org\/10.1186\/s12886-026-04909-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8501876\/v1","asserted-by":"object"}]},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"2 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal care was compliant with the\n                      Guide for the Care and Use of Laboratory Animals\n                      (8th Edition, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council; National Academy Press; Washington, D.C., 2011) and the U.S. Department of Agriculture through the Animal Welfare Act (Public Law 99\u2013198). The study was conducted at JOINN Laboratories (Suzhou, China) in compliance with good laboratory practice (GLP) regulations. The study was reviewed and approved by the Institutional Animal Care and Use Committees at JOINN Laboratories to ensure that the study was carried out in an ethical manner.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Songhomitra Panda-Jonas, Jost B. Jonas: European patent EP 3 271 392, JP 2021-119187, and US 12,024,557: \u201e Agents for use in the therapeutic or prophylactic treatment of myopia or hyperopia; European patent application 23196899.1 \u201eEGFR Antagonists for the treatment of diseases involving unwanted migration, proliferation, and metaplasia of retinal pigment epithelium (RPE) cells. All other authors: None.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"412"}}